Abiopharma

🔍 STUNTZ LINDA G (Executive)

Company: EDISON INTERNATIONAL (EIX)

Report Date: 2026-04-23

Detailed Transactions and Holdings:

• Acquired 2,737 shares of Deferred Stock Unit (Derivative)
  Date: 2026-04-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 27,222.05 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4

Footnotes:

• F1: 1 for 1: Each deferred stock unit is equal in value to one share of Edison International Common Stock.
• F2: The deferred stock units were granted to the Reporting Person upon re-election as a director at the Issuer's annual meeting.
• F3: The deferred stock units are to be settled upon the Reporting Person's retirement, resignation, death or disability, unless another date(s) is elected by the Reporting Person.
• F4: Includes additional deferred stock units acquired pursuant to dividend reinvestment and exempt from reporting under Section 16(a).